Bombesin-like peptide receptor subtypes promote mitogenesis, which requires persistent receptor signaling

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1346-1354

  Feldman, Richard I ^a   Bartholdi, Marty F ^a   James, M W U ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOMBESIN DERIVATIVE; RECEPTOR SUBTYPE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CELL GROWTH; CELL TRANSFORMATION; DNA SYNTHESIS; GROWTH REGULATION; HUMAN; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

3T3 CELLS; ANIMALS; CELL CYCLE; CELL DIVISION; DNA; HUMANS; MICE; MICE, INBRED BALB C; MITOGENS; RECEPTORS, BOMBESIN; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0029807604     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Erspamer, V. Discovery, isolation, and characterization of bombesin-like peptides. Ann. N. Y. Acad. Sci. 547:3-9 (1988).
2. Lebacq-Verheyden, A. M., A. M. Trepel, E. A. Sausville, and J. F. Battey. Bombesin and gastrin releasing peptide: neuropeptides, secretagogues, and growth factors. Handb. Exp. Pharmacol. 95:71-124 (1990).
3. Nelson, J., M. Donnelly, B. Walker, J. Gray, C. Shaw, and R. F. Murphy. Bombesin stimulates proliferation of human breast cancer cells in culture. Br. J. Cancer 63:933-936 (1991).
4. Alexander, R. W., J. R. Upp, Jr., G. J. Posten, V. Gupta, C. M. Townsend, Jr., and J. C. Thompson. Effects of bombesin on growth of human small cell lung carcinoma in vivo. Cancer Res. 48:1439-1441 (1988).
5. Carney, D. N., F. Cuttitta, T. W. Moody, and J D. Minna. Selective stimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res. 47:821-825 (1987).
6. Narayan, S., E. R. Spindel, N. H. Rubin, and P. Singh. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects. Cell Growth Differ. 3:111-118 (1992).
7. Bologna, M., C. Festuccia, P. Muzi, L. Biordi, and M. Ciomei. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63: 1714-1720 (1989).
8. Szepeshazi, K., A. V. Schally, R. Z. Cai, S. Radulovic, S. Milovanovic, and B. Szoke. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters. Cancer Res. 51:5980-5986 (1991).
9. Radulovic, S., G. Miller, and A. V. Schally. Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res. 51:6006-6009 (1991).
10. Szepeshazi, K., A. V. Schally, G. Halmos, K Groot, and S. Radulovic. Growth inhibition of estrogen-dependent and estrogen-independent MXT mammary cancers in mice by the bombesin and gastrin-releasing peptide antagonist RC-3095. J. Natl. Cancer Inst. 84:1915-1922 (1992).
11. Mahmoud, S., J. Staley, J. Taylor, A. Bogden, J. P. Moreau, D. Coy, I. Avis, F. Cuttitta, J. L. Mulshine, and T. W. Moody. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res. 51:1798-1802 (1991).
12. Cuttitta, F., D. N. Carney, J. Mulshine, T. W. Moody, J. Fedorko, A. Fischler, and J. D. Minna. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature (Lond.) 316:823-826 (1985).
13. Pinski, J., A. V. Schally, G. Halmos, K. Szepeshazi, and K. Groot. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res. 54:5895-5901 (1994).
14. Battey, J. F., J. M. Way, M. H. Corjay, H. Shapira, K. Kusano, R. Harkins, J. M. Wu, T. Slattery, E. Mann, and R. I. Feldman. Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 88:395-399 (1991).
15. Corjay, M. H., D. J. Dobrzanski, J. M. Way, J. Viallet, H. Shapira, P. Worland, E. A. Sausville, and J. F. Battey. Two distinct bombesin receptor subtypes are expressed and functional in human lung carcinoma cells. J. Bid. Chem. 266:18771-18779 (1991).
16. Spindel, E. R., E. Giladi, P. Brehm, R. H. Goodman, and T. P. Segerson. Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/gastrin-releasing peptide receptor. Mol. Endocrinol. 4:1956-1563 (1990).
17. Fathi, Z., M. H. Corjay, H. Shapira, E. Wada, R. Benya, R. Jensen, J. Viallet, E. A. Sausville, and J. F. Battey. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells. J. Biol. Chem. 268:5979-84 (1993).
18. Gorbulev, V., A. Akhundova, H. Buchner, and F. Fahrenholz. Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur. J. Biochem. 208:405-410 (1992).
19. Wu, J. M. D. E. Nitecki, S. Biancalana, and R. I. Feldman. Discovery of high affinity bombesin receptor subtype 3 agonists. Mol. Pharmacol. 50: 1355-1363 (1996).
20. Rozengurt, E., and J. Sinnett-Smith. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 80:2936-2940 (1983).
21. Wu, J. M., D. O. Hoang, and R. I. Feldman. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs. Mol. Pharmacol. 47:871-881 (1995).
22. Benya, R. V., T. Kusui, F. Shikado, J. F. Battey, and R. T. Jensen. Desensitization of neuromedin B receptors (NMB-R) on native and NMB-R-transfected cells involves down-regulation and internalization. J. Biol. Chem. 269:11721-8 (1994).
23. 2+ and phosphoinositides. Biochem. J. 286:641-648 (1992).
24. Benya, R. V., T. Kusui, T. K. Pradhan, J. F. Battey, and R. T. Jensen. Expression and characterization of cloned human bombesin receptors. Mol. Pharmacol. 47:10-20 (1995).
25. Feldman, R. I., S. Fried, E. Mann, J. M. Wu, and M. Liang. Gastrin-releasing peptide receptor signaling resulting in growth inhibition. Mol Pharmacol. 49:505-514 (1996).
26. Munson, P. J. LIGAND: a computerized analysis of ligand binding data. Methods Enzymol. 92:543-576 (1983).
27. Dietrich, J. B., P. Hildebrand, L. B. Jeker, A. Pansky, A. N. Eberle, and C. Beglinger. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells. Regul. Pept. 53:165-173 (1994).
28. Wang, L. H., D. H. Coy, J. E. Taylor, N. Y. Jiang, S. H. Kim, J. P. Moreau, S. C. Huang, S. A. Mantey, H. Frucht, and R. T. Jensen. Desmethionine alkylamide bombesin analogues: a new class of bombesin receptor antagonists with potent antisecretory activity in pancreatic acini and antimitotic activity in Swiss 3T3 cells. Biochemistry 29:616-622 (1990).
29. Zhan, X., X. Hu, R. Friesel, and T. Maciag. Long term growth factor exposure and differential tyrosine phosphorylation are required for DNA synthesis in BALB/c 3T3 cells. J. Biol. Chem. 268:9611-9620 (1993).
30. Zhan, X., X. Hu, B. Hampton, W. H. Burgess, R. Friesel, and T. Maciag. Murine cortactin is phosphorylated in response to fibroblast growth factor-1 on tyrosine residues late in the G1 phase of the BALB/c 3T3 cell cycle. J. Biol. Chem. 268:24427-24431 (1993).
31. Rozengurt, E. Early signals in the mitogenic response. Science (Washington D. C.) 234:161-166 (1986).
32. Rozengurt, E., and J. W. Sinnett-Smith. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response. J. Cell. Physiol. 131:218-225 (1987).
33. Millar, J. B., and E. Rozengurt. Arachidonic acid release by bombesin. A novel postreceptor target for heterologous mitogenic desensitization. J. Biol. Chem. 265:19973-19979 (1990).
34. Sinnett-Smith, J., I. Zachary, A. M. Valverde, and E. Rozengurt. Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton. J. Biol. Chem. 268:14261-14268 (1993).
35. Pang, L., S. J. Decker, and A. R. Saltiel. Bombesin and epidermal growth factor stimulate the mitogen-activated protein kinase through different pathways in Swiss 3T3 cells. Biochem. J. 289:283-287 (1993).
36. Van Lint, J., P. Agostinis, W. Merlevede, and J. R. Vandenheede. Early responses in mitogenic signaling, bombesin induced protein phosphorylations in Swiss 3T3 cells. Adv. Enzyme Regul. 33:143-155 (1993).
37. Currie, S., G. L. Smith, C. A. Crichton, C. G. Jackson, C. Hallam, and M. J. Wakelam. Bombesin stimulates the rapid activation of phospholipase A2-catalyzed phosphatidylcholine hydrolysis in Swiss 3T3 cells. J, Biol. Chem. 267:6056-6062 (1992).
38. Benya, R. V., T. Kusui, J. F. Battey, and R. T. Jensen. Chronic desensitization and down-regulation of the gastrin-releasing peptide receptor are mediated by a protein kinase C-dependent mechanism. J. Biol. Chem. 270:3346-3352 (1995).
39. Dobrzanski, D., Y. Sharoni, E. Wada, J. Battey, and E. Sausville. Neuromedin-B receptor transfected BALB/3T3 cells: signal transduction and effects of ectopic receptor expression on cell growth. Regul. Pept. 45:341-352 (1993).
40. Alexander, R. W., J. R. Upp, Jr., G. J. Posten, C. M. Townsend, Jr., P. Singh, and J. C. Thompson. Bombesin inhibits growth of human pancreatic adenocarcinoma in nude mice. Pancreas 3:297-302 (1988).
41. Farre, A., J. Ishizuka, G. Gomez, B. M. Evers, R. Saydjari, J. Y. Koo, C. M. Townsend, Jr., and J. C. Thompson. Bombesin inhibits growth of pancreatic ductal adenocarcinoma (H2T) in nude mice. Pancreas 9:652-656 (1994).